期刊文献+

系统性红斑狼疮合并深部真菌感染102例临床分析 被引量:11

Clinical analysis of deep fungal infections in 102 patients with systemic lupus erythematosus
下载PDF
导出
摘要 目的:探讨SLE合并深部真菌感染的病原学特征、易感因素、治疗和转归。方法:对住院治疗的102例SLE合并深部真菌感染患者的临床资料进行回顾性分析。结果:102例真菌感染患者占同期住院1350例SLE患者的7.6%,其中39例(38.2%)为医院内感染。感染部位最常见为肺(37.5%),其次为胃肠道和泌尿生殖道。20例发生2个或2个以上部位的感染。病原菌以白假丝酵母菌为主(40.6%),其次为热带假丝酵母菌、光滑假丝酵母菌和新生隐球菌。易感因素前3位为长期接受肾上腺皮质激素(激素)治疗者、联合应用免疫抑制剂者、低蛋白血症者。根据病原菌选择抗真菌药物,氟康唑、两性霉素B、伊曲康唑和伏立康唑为主要治疗药物。治愈48例,好转28例,未愈5例,死亡21例,病死率为20.6%。结论:SLE患者合并深部真菌感染率高,且病死率高。多部位感染常见,以肺部为感染的高发部位,病原菌以白假丝酵母菌为主,长期接受激素、免疫抑制剂、广谱抗生素治疗和侵入性操作等是其常见易感因素。建议在治疗原发病的同时做好真菌感染的防治工作,有助于改善SLE的预后。 Objective: To discuss the etiology, risk factors, antifungal therapy and outcomes of deep fungal infections in patients with SLE. Methods: Retrospective analysis was performed in 102 hospitalized SLE patients with deep fungal infections. Resuits: Among 1 350 SLE patients, 102 cases had deep fungal infections with an incidence of 7.6 % , of which 39 cases (38.2%) were nosocomial infections. Lung was the most common infection site (37.5%), followed by gastrointestinal tract and urogenital tract. Twenty patients had two or more loci of infection. The most common pathogenic microorganism was Candida albicans (40. 6% ), followed by Candida tropical, Candida smooth and Cryptococcus neoformans. The major risk factors were long-term use of corticosteroids, immunosuppressants and hypoproteinemia. The selection of antifungal drugs was based on pathogen. Fluconazole, amphotericin B, itraconazole and voriconazole were the main drugs. Of all the cases, 48 were cured, 28 improved, 5 were not effective and 21 died, with a mortality of 20. 6%. Conclusion: SLE patients are prone to complication of deep fungal infections with high mortality. The most common infection site is the lung and the most common pathogenic microorganism is Candida albicans. The common risk factors are invasive operation, long-term use of corticosteroids, immunosuppressants and broad-spectrum antibiotics. Clinicians should pay more attention to SLE for deep fungal infections. Early diagnosis and rational treatment could improve the prognosis.
出处 《新医学》 北大核心 2008年第9期578-580,共3页 Journal of New Medicine
基金 广东省科技计划基金资助项目(2005B30701001)
关键词 红斑狼疮 系统性 深部真菌感染 易感因素 治疗 预后 Lupus erythematosus, systemic Deep fungal infection Risk factors Therapy Prognosis
  • 相关文献

参考文献6

二级参考文献49

  • 1杜斌,张海涛,陈德昌,刘大为,侯百东,熊雯,刘彤华,陈杰.3447例尸检病例的深部真菌感染分析[J].中华医学杂志,1996,76(5):352-354. 被引量:119
  • 2Bellomio V, Spindler A, Lucero E, et al. Systemic lupus erythematosus: mortality and survival in Argentina: a muhicenter study Lupus, 2000, 9: 377-381.
  • 3Ginzler EM, Diamond HS, Weiner M, et al. A multicenter study of outcome in systemic lupus erythematosus (Part 1 ): entry variables as predictors of prognosis. Arthritis Rheum, 1982, 25: 601-611.
  • 4Abu-Shakra M, IJrowitz MB, Gladman DD, et al. Mortality study in systemic lupus erythematosus, Results from a single center. 1. Causes of death. J Rheumatol, 1995, 22: 1259-1264.
  • 5Abu-Shakra M, Gladman DD, IJrowitz MB, et al. Mortality stud- ies in SLE: how far can we improve survival of patients with SLE. Autoimmun Rev, 2004, 3: 418-420.
  • 6Cervera R, Khamashta MA, Font J, et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1000 patients. Medicine (Baltimore), 2003, 82: 299-308.
  • 7Trager J, Ward MM. Mortality and causes of death in systemic lupus erythematosus. Curr Opin Rheumatol, 2001, 13: 345-351.
  • 8Cervera R, Khamashta MA, Font J, et al. Morbidity and mortality in systemic lupus erythematosus during a 5-year period: a multicenter prospective study of 1000 patients. Medicine (Baltimore), 1999, 78: 167-175.
  • 9Jacobsen S, Petersen J, Ullman S, et al. Mortality and causes of deaths of 513 Danish patients with systemic lupus erythematosus, Scand J Rheumatoi, 1999, 28: 75-80.
  • 10Cook RJ, Gladman DD, Pericak D, et al. Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity. J Rheumatol, 2000, 27: 1892- 1895.

共引文献235

同被引文献68

  • 1王春燕,李挺.系统性红斑狼疮真菌感染的易感因素分析[J].兰州大学学报(医学版),2013,39(4):37-40. 被引量:5
  • 2孙乐栋,曾抗,刁友涛,林子刚,周再高,兰海梅.系统性红斑狼疮患者口腔念珠菌感染的调查研究[J].临床皮肤科杂志,2005,34(5):298-298. 被引量:7
  • 3刘明,姜格宁.肺隐球菌病的外科治疗[J].中华结核和呼吸杂志,2006,29(5):307-309. 被引量:34
  • 4苏励,茅建春,顾军花.环磷酰胺联合大剂量黄芪注射液静脉滴注治疗狼疮性肾炎[J].中西医结合学报,2007,5(3):272-275. 被引量:17
  • 5Merrell M,Shulman LE.Determination of prognosis in chronic disease,illustrated by systemic lupus erythematosus.J Chronic Dis 1955;1(1):12-32.
  • 6Cervera R,Khamashta MA,Font J,et al.Morbidity and mortality in systemic lupus erythematosua during a 10-year period:a comparison of early and late manifestations in a cohort of 1000 patients.Medicine 2003;82(5):299-308.
  • 7Abu-Dhakra M,Urowitz MB,Gladman DD,et al.Mortality studies in systemic lupus erythematosus.Results form a single center I.Causes of death.J Rheumatol 1995;22(7):1259-1264.
  • 8Zandman-Goddard G,Shoenfeld Y.Infections and SLE.Autoimmunity 2005;38(7):473-485.
  • 9Ward MM, Pyun E, Studenski S. Causes of death in systemic lupus ery- thematosus. Long-term follow-up of an inception cohort [ J ]. Arthritis Rheum, 1995,38 (10) : 1492-1499.
  • 10Saag MS, Graybill R J, Larsen RA, et al. Practice guidelines for the man- agement of cryptococcal disease[J~. Clin Infect Dis,2000,30(4) :710- 718.

引证文献11

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部